//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,075.9093.1
Stock Analysis, IPO, Mutual Funds, Bonds & More

GlaxoSmithKline Consumer Healthcare Ltd.

ET 500

Rank 2018
289
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:58 | 13-09-2019
  • BSE
    16:01 | 13-09-2019
7800.30

Today's Change

14.80 (0.19%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

23,933

Open

7785.50

Prev. Close

7785.50

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)10.00
  • EPS-TTM (Rs.)245.02
  • BV/share (₹)973.64
  • 52Wk L/H6310.00/ 8160.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed

GlaxoSmithKline Consumer Healthcare Ltd Stock Price F & O Quotes

What's your view on GlaxoSmithKline Consumer Healthcare for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on GlaxoSmithKline Consumer Healthcare Ltd.

GlaxoSmithKline Consumer Healthcare Ltd.
Quarterly Results

Figures in Rs. Cr
Jun 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
1,194.32
-7.13
7.87
784.36
1194.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Operating Profit
280.40
-11.96
21.76
306.78
679.82
Other Income
126.58
3.00
31.24
14.11
126.58
EBITDA
406.98
-7.79
24.56
50.48
406.98
Interest
1.70
750.00
844.44
1.70
20.59
Depreciation
19.62
31.50
33.47
12.48
19.62
Tax
137.58
-2.04
23.48
5.67
137.58
Net Profit
248.08
-13.20
23.77
11.74
248.08
EPS (₹)
58.98
-13.20
23.75
0.06
58.98

GlaxoSmithKline Consumer Healthcare Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
7800.30
0.19
-1.17
-0.22
0.46
5.43
27.55
51.70
29.35
-0.84
10.13
-10.93
-26.90
-41.24
44.58
114.23
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

GlaxoSmithKline Consumer Healthcare Ltd Risk Return Comparison

with peersNew

GlaxoSmithKline Consumer Healthcare Ltd
Financial Comparison

with peers
Management Efficiency
GlaxoSmithKline Consumer Healthcare Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
24.00
-1.23
-1.23
-1.23
Return on Assets (%)
16.19
-2.28
-2.28
-2.28
Return on capital Employed (%)
20.22
-1.00
-1.00
-1.00
Fixed Assets Turnover (x)
1.26
0.29
0.29
0.29
Profitability and Growth
Gross Profit Margin (%)
22.59
-2.60
-2.60
-2.60
Operating Profit Margin(%)
23.85
1.80
1.80
1.80
Net Profit margin (%)
20.55
-3.20
-3.20
-3.20
Financial Strength
Liquidity
Quick Ratio (x)
2.54
3.07
3.07
3.07
Current Ratio (x)
2.83
3.50
3.50
3.50
Cash ratio (x)
2.08
0.05
0.05
0.05
Solvency
Debt Equity Ratio (x)
0.00
0.00
0.00
0.00
Coverage Ratios
Cash flows to long term debt (x)
0.00
0.18
0.18
0.18
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

GlaxoSmithKline Consumer Healthcare Ltd Share Holding as on 30-06-2019

CategoryNo. of sharesPercentage
ForeignInstitutions1,765,2654.20
ForeignPromoter30,471,99272.46
GeneralPublic5,130,33512.20
Others1,774,7254.22
NBanksMutualFunds1,689,8354.02
FinancialInstitutions1,223,3862.91

MF Ownership Of GlaxoSmithKline Consumer Healthcare Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
IDFC Focused Equity Direct-G
Portfolio as on 31-08-2019
Equity: Multi Cap
108400
-4.00%
6.35%
87.83
Reliance Arbitrage Direct-G
Portfolio as on 31-08-2019
Hybrid: Arbitrage
95562
60.84%
0.87%
77.43
Tata India Consumer Direct-G
Portfolio as on 31-08-2019
Equity: Thematic-Consumption
87800
0.00%
5.39%
71.14
IDFC Core Equity Direct-G
Portfolio as on 31-08-2019
Equity: Large & MidCap
56353
0.00%
1.71%
45.66

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About GlaxoSmithKline Consumer Healthcare Ltd.

GlaxoSmithKline Consumer Healthcare Ltd., incorporated in the year 1958, is a Large Cap company (having a market cap of Rs 32810.89 Crore) operating in FMCG sector.

GlaxoSmithKline Consumer Healthcare Ltd. key Products/Revenue Segments include Food Products which contributed Rs 4515.03 Crore to Sales Value (94.41 % of Total Sales), Other Operating Revenue which contributed Rs 241.32 Crore to Sales Value (5.04 % of Total Sales), Export Incentives which contributed Rs 17.55 Crore to Sales Value (0.36 % of Total Sales), Miscellaneous Income which contributed Rs 8.10 Crore to Sales Value (0.16 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-06-2019, the company has reported a Standalone sales of Rs 1194.32 Crore, down -7.13 % from last quarter Sales of Rs 1286.06 Crore and up 7.87 % from last year same quarter Sales of Rs 1107.14 Crore Company has reported net profit after tax of Rs 248.08 Crore in latest quarter.

The company’s top management includes Mr.Anup Dhingra, Mr.Navneet Saluja, Mr.P V Bhide, Mr.Patnam Dwarakanath, Mr.S Madhavan, Mr.Vivek Anand, Ms.Sangeeta Talwar. Company has Deloitte Haskins & Sells LLP as its auditoRs As on 30-06-2019, the company has a total of 42,055,538 shares outstanding.

Close X
AlertWatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors